Get the latest local stories in your inbox.
Science, Tech & Medicine in ...
A fungus and three bacteria now top the CDC's danger list, with one infection fatal in up to 62% of cases.
NASA seeks industry responses by Nov. 30 on ways to boost or safely retire Hubble before an uncontrolled reentry.
A Cessna Caravan flew coast to coast with zero pilot inputs, as California-based Joby expanded its Air Force contract.
A San Francisco team is working nonstop to stop ChatGPT misuse, while tests show chatbots still flub voting facts nearly 14% of the time.
Jeff Yan calls Hyperliquid a layer like the internet itself — and he wants obligations to fall on builders, not the network.
Elon Musk reportedly discussed buying EchoStar's Boost Mobile with chairman Charlie Ergen in October to speed up Starlink's phone ambitions.
Dr. Reddy's generic lenacapavir could reach low-income countries by year's end, slashing a drug that costs $28,218 in the U.S. to just $40.
The Tobaccoville-area maker now has 67 FDA-authorized nicotine pouches on the market, with eight new Velo varieties cleared Friday.
The FCC plan targets China Mobile, China Telecom and China Unicom over Salt Typhoon spying fears tied to U.S. call data.
New limits on iodine, manganese and vitamins A and D could reshape every can on store shelves nationwide.
Anil Menon and Joshua Kutryk spent over seven hours outside the ISS installing a 60-foot solar array.
A new radioligand therapy attacks advanced prostate cancer cell by cell, and Frederick doctors say it can work after just one treatment.
NHTSA's new proposal would put glowing cyan lamps on robotaxis nationwide, building on a color Mercedes-Benz already tested in Nevada.
Please enable JavaScript to select your regional newsletters and subscribe.
Choose one or more regions. Get the latest local stories when there is news to share.
Select the local newsletters you’d like to receive, then subscribe.
0 regions selected
No matching regions. Try another search.
Free. Unsubscribe anytime. Daily when new stories are available.
Open the standalone signup form
Subscribe to Hoodline newsletters